Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

NCT00116129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDIV

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Ibutamoren Mesylate (MK-0677)

Sponsor

Bennett, Robert, M.D.

Collaborators

[object Object]